Hanson Wade

R&D

Partner Content

2nd Covalent Drug Discovery & Development Summit

Discover & Develop Selective, Clinically Validated & Novel Covalent Therapeutics to Expand the Targetable Proteome & Non-Cystine Amino Acid Space in Oncology, Immunology & B

R&D

Partner Content

5th Gene Therapy Immunogenicity Summit

Optimise Safety & De-Risk Efficacy of Viral Vector Based Gene Therapies

R&D

Partner Content

2nd CRISPR-Based Therapy Analytical Development Summit

Fostering Analytical Gold Standards for Genome Editing Therapies

R&D

Partner Content

3rd Lipid Nanoparticles Development Summit Europe

Unlock LNP potential with enhanced clinical translatability at the 3rd Lipid Nanoparticles Development Summit Europe (24-26 September, Berlin, Germany), the leading dedicated LNP f

R&D